Výsledky vyhledávání - Marcus Unterrainer
- Zobrazuji výsledky 1 - 20 z 30
- Přejít na další stránku
-
1
First Clinical Results for PSMA-Targeted α-Therapy Using <sup>225</sup>Ac-PSMA-I&T in Advanced-mCRPC Patients Autor Mathias J. Zacherl, Franz Josef Gildehaus, Lena M. Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina-Sophie Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica, Harun Ilhan
Vydáno 2020Artigo -
2
<sup>18</sup>F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use Autor Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, Christophe M. Deroose
Vydáno 2023Revisão -
3
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma Autor Bogdana Suchorska, Armin Giese, Annamaria Biczok, Marcus Unterrainer, Michael Weller, Mark Drexler, Peter Bartenstein, Ulrich Schüller, Jörg‐Christian Tonn, Nathalie L. Albert
Vydáno 2017Artigo -
4
Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment? Autor Marcus Unterrainer, Franziska Vettermann, Matthias Brendel, Adrien Holzgreve, Michael Lifschitz, Matthias Zähringer, Bogdana Suchorska, Vera Wenter, Ben Illigens, Peter Bartenstein, Nathalie L. Albert
Vydáno 2017Artigo -
5
Serial <sup>18</sup>F-FET PET Imaging of Primarily <sup>18</sup>F-FET–Negative Glioma: Does It Make Sense? Autor Marcus Unterrainer, Florian Schweisthal, Bogdana Suchorska, Vera Wenter, Christine Schmid‐Tannwald, Wolfgang P. Fendler, Ulrich Schüller, Peter Bartenstein, Jörg‐Christian Tonn, Nathalie L. Albert
Vydáno 2016Artigo -
6
<sup>18</sup>F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis Autor Marcus Unterrainer, Norbert Galldiks, Bogdana Suchorska, Lara-Caroline Kowalew, Vera Wenter, Christine Schmid‐Tannwald, Maximilian Niyazi, Peter Bartenstein, Karl‐Josef Langen, Nathalie L. Albert
Vydáno 2016Artigo -
7
RECIP 1.0 + PSA for response assessment in mCRPC patients treated with 225Ac / 177Lu PSMA combination therapy Autor Gabriel T. Sheikh, Astrid Delker, Mathias J. Zacherl, Adrien Holzgreve, Sarah L. Takayama Fouladgar, Marcus Unterrainer, Johannes Rübenthaler, Jozefina Casuscelli, Andrei Gafita, Lena M. Unterrainer
Vydáno 2025Artigo -
8
Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties? Autor Alexander Romagna, Marcus Unterrainer, Christine Schmid‐Tannwald, Matthias Brendel, Jörg‐Christian Tonn, Silke Birgit Nachbichler, Alexander Muacevic, Peter Bartenstein, Friedrich-Wilhelm Kreth, Nathalie L. Albert
Vydáno 2016Artigo -
9
Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics Autor Zhicong Li, Lena Kaiser, Adrien Holzgreve, Viktoria Ruf, Bogdana Suchorska, Vera Wenter, Stefanie Quach, Jochen Herms, Peter Bartenstein, Jörg‐Christian Tonn, Marcus Unterrainer, Nathalie L. Albert
Vydáno 2021Artigo -
10
Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival Autor Simon Rudisile, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Guido Böning, Franz Josef Gildehaus, Wolfgang P. Fendler, Christoph J. Auernhammer, Christine Spitzweg, Peter Bartenstein, Andrei Todica, Harun Ilhan
Vydáno 2019Artigo -
11
[99mTc]Tc-antigranulocyte scintigraphy for prediction of bone marrow reserve prior to radioligand therapy in patients with metastatic castration resistant prostate cancer Autor Sophie C. Kunte, Astrid Delker, Adrien Holzgreve, Mathias J. Zacherl, Maximilian Scheifele, Jozefina Casuscelli, Franz Josef Gildehaus, Marcus Unterrainer, Harun Ilhan, Rudolf A. Werner, Lena M. Unterrainer
Vydáno 2025Artigo -
12
PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions Autor Marcus Unterrainer, Michael Ruzicka, Matthias P. Fabritius, Lena M. Mittlmeier, Michael Winkelmann, Johannes Rübenthaler, Matthias Brendel, Marion Subklewe, Michael von Bergwelt‐Baildon, Jens Ricke, Wolfgang G. Kunz, Clemens C. Cyran
Vydáno 2020Revisão -
13
Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients Autor Veit M. Stoecklein, Sophia Stoecklein, Franziska Galiè, Jianxun Ren, Michael Schmutzer, Marcus Unterrainer, Nathalie L. Albert, Friedrich-W Kreth, Niklas Thon, Thomas Liebig, Birgit Ertl‐Wagner, Joerg-C. Tonn, Hesheng Liu
Vydáno 2020Artigo -
14
TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis Autor Lena Vomacka, Nathalie L. Albert, Simon Lindner, Marcus Unterrainer, Christoph Mahler, Matthias Brendel, Larissa Ermoschkin, Astrid Gosewisch, Anika Brunegraf, Christopher Buckley, Tania Kümpfel, Rainer Rupprecht, Sibylle Ziegler, Martin Kerschensteiner, Peter Bartenstein, Guido Böning
Vydáno 2017Artigo -
15
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions Autor Chukwuka Eze, Nina-Sophie Schmidt-Hegemann, Lino M. Sawicki, Julian Kirchner, Olarn Roengvoraphoj, Lukas Käsmann, Lena M. Mittlmeier, Wolfgang G. Kunz, Amanda Tufman, Julien Dinkel, Jens Ricke, Claus Belka, Farkhad Manapov, Marcus Unterrainer
Vydáno 2021Revisão -
16
PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imagin... Autor Adrien Holzgreve, Annamaria Biczok, Viktoria Ruf, Friederike Liesche‐Starnecker, Katja Steiger, Maximilian A. Kirchner, Marcus Unterrainer, Lena M. Mittlmeier, Jochen Herms, Jürgen Schlegel, Peter Bartenstein, Jörg‐Christian Tonn, Nathalie L. Albert, Bogdana Suchorska
Vydáno 2021Artigo -
17
Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Autor Dirk Mehrens, Kristina K. M. Kramer, Lena M. Unterrainer, Leonie Beyer, Peter Bartenstein, Matthias F. Froelich, Fabian Tollens, Jens Ricke, Johannes Rübenthaler, Nina-Sophie Schmidt-Hegemann, Annika Herlemann, Marcus Unterrainer, Wolfgang G. Kunz
Vydáno 2023Artigo -
18
Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application I... Autor Markus Hofmann, Sophie C. Kunte, Marcus Unterrainer, Astrid Delker, Adrien Holzgreve, Johannes Toms, F.J. Gildehaus, Christoph J. Auernhammer, Christine Spitzweg, Mathias J. Zacherl, Harun Ilhan, Johannes Rübenthaler, Leonie Beyer, Lena M. Unterrainer
Vydáno 2025Artigo -
19
Photopenic defects on O-(2-[18F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients Autor Norbert Galldiks, Marcus Unterrainer, Natalie Judov, Gabriele Stoffels, Marion Rapp, Philipp Lohmann, Franziska Vettermann, Veronika Dunkl, Bogdana Suchorska, Jörg C. Tonn, Friedrich-Wilhem Kreth, Gereon R. Fink, Peter Bartenstein, Karl‐Josef Langen, Nathalie L. Albert
Vydáno 2019Artigo -
20
Recent advances of PET imaging in clinical radiation oncology Autor Marcus Unterrainer, Chukwuka Eze, Harun Ilhan, Sebastian Marschner, Olarn Roengvoraphoj, Nina-Sophie Schmidt-Hegemann, Franziska Walter, W. G. Kunz, Per Munck af Rosenschöld, Robert Jeraj, Nathalie L. Albert, Anca‐Ligia Grosu, Maximilian Niyazi, Peter Bartenstein, Claus Belka
Vydáno 2020Revisão
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Nuclear medicine
Radiology
Oncology
Positron emission tomography
Cancer
Biology
Pathology
Prostate cancer
Cancer research
Neuroscience
Medical physics
Psychology
Disease
Glioma
Radiation therapy
Translocator protein
Urology
Gene
Immunology
Inflammation
Microglia
Neuroendocrine tumors
Neuroinflammation
Radionuclide therapy
Receptor
Adverse effect
Basal ganglia
Biochemistry